scispace - formally typeset
Open AccessJournal ArticleDOI

Urgent needs of low-income and middle-income countries for COVID-19 vaccines and therapeutics

Reads0
Chats0
TLDR
The COVAX Facility of the ACT Accelerator has agreements to access 2 billion doses of WHO prequalified vaccines during 2021, but this represents only 20% of the vaccine needs of participating countries Most low-income and middle-income countries face difficulties in accessing and delivering vaccines and therapeutics for COVID-19 to their populations.
About
This article is published in The Lancet.The article was published on 2021-02-13 and is currently open access. It has received 98 citations till now.

read more

Citations
More filters
Journal ArticleDOI

Barriers and facilitators of HPV vaccination in sub-saharan Africa: a systematic review

TL;DR: In this paper , a systematic review aims to identify barriers and facilitators of HPV vaccination in sub-Saharan Africa (SSA) to inform national implementation strategies in the region and to contribute to the implementation of more effective vaccination programs targeted at eliminating cervical cancer.
Journal ArticleDOI

Assessment of the COVID-19 vaccine market landscape in 2021 relative to challenges in low- and middle-income countries

TL;DR: Key policy recommendations included increasing technology transfer to LMICs, developing international legal mechanisms to prevent export bans, and increasing investment in vaccine candidates with more favorable distribution profiles.
References
More filters
Journal ArticleDOI

Reserving coronavirus disease 2019 vaccines for global access: cross sectional analysis.

TL;DR: This study provides an overview of how high income countries have secured future supplies of covid-19 vaccines but that access for the rest of the world is uncertain.
Journal ArticleDOI

Potential effects of vaccinations on the prevention of COVID-19: rationale, clinical evidence, risks, and public health considerations.

TL;DR: This review will discuss the available immunologic and clinical evidence to support the benefit of the influenza, pneumococcal, and tuberculosis vaccines in the context of COVID-19 as well as to provide an overview on the CO VID-19-specific vaccines that are in the development pipeline.
Journal ArticleDOI

Strengthening medical product regulation in low- and middle-income countries.

TL;DR: Charles Preston and colleagues use case studies to describe how regulatory systems for medical products and medicines must be strengthened in low and middle income countries to assure adequate quality, safety and efficacy.
Related Papers (5)